Berlin, Germany and Washington, DC, USA – Eckert & Ziegler Strahlen- und Medizintechnik AG (ISIN DE0005659700), specialists in radioactive pharmaceuticals and their production technology, has entered into an agreement with Bioscan Inc., located in Washington, DC, to acquire its radiopharmaceutical equipment business. The transaction involves both analytical instruments used in quality assurance of radioactive pharmaceuticals […]
HOLLISTON, Mass. – Harvard Bioscience, Inc. (Nasdaq:HBIO – News), a global developer, manufacturer, and marketer of a broad range of tools to advance life science research and regenerative medicine, today announced that it has acquired the preclinical business unit of CMA Microdialysis AB through a purchase of assets. CMA Microdialysis AB is a privately held […]
CARLSBAD, Calif. – International Stem Cell Corporation (OTCBB:ISCO) (www.intlstemcell.com), the first company to perfect a method of creating human “parthenogenetic” stem cells derived from unfertilized human eggs, reports that its wholly owned subsidiary, Lifeline Cell Technology (Lifeline), grew 2011 first quarter product sales by 35% and gained well over 200 new customers compared with the […]
Vancouver, BC, Canada – Boreal Genomics, the developer of the SCODA nucleic acid purification and sequence specific target enrichment technology, announced today that Nitin Sood has been appointed Chief Executive Officer and member of the company’s Board of Directors. Sood joins founder and Chief Scientific Officer, Dr. Andre Marziali, who will continue serving as a […]
HOPKINTON, Mass. and GAITHERSBURG, Md. – Caliper Life Sciences, Inc. (NASDAQ: CALP) today announced a collaboration with Edge BioSystems, Inc., an innovative sequencing service provider based in Gaithersburg, Md. EdgeBio and Caliper will co-develop automated protocols for the 5500xl, SOLiD 4, and Ion Torrent Personal Genome Machine (PGM) systems on Caliper’s Sciclone® NGS Workstation, and […]
SOUTH EASTON, Mass. – Pressure BioSciences, Inc. (Nasdaq:PBIO) (“PBI” or the “Company”) today announced that Mr. Jeffrey N. Peterson, CEO of Target Discovery, Inc. (Palo Alto, CA), was elected to the Company’s Board of Directors effective Tuesday, June 21, 2011. The Company also announced that it has received gross proceeds of approximately $275,000 from the […]
PLEASANTON, CA and COVENTRY, UNITED KINGDOM – IntegenX Inc. (IXI) today announced an Early Access Program for its RapidHIT™ 200 Human Identification System. The Early Access program is designed to provide IXI’s global partners with advance product access and training. Early Access partners will receive pre-production prototypes of the RapidHIT 200 instrument, disposable reagent cartridges […]
PLEASANTON, CA – IntegenX Inc. (IXI) disclosed today that the company’s RapidHIT(TM) 200 Human DNA Identification System repeatedly delivered correct identifications in less than two hours during simulated operational scenarios conducted by the US Department of Defense (DOD). Engineers and technicians from several companies participated in a two-week DOD event featuring tactical scenarios designed to […]
SAN DIEGO – Sequenom, Inc. (NASDAQ: SQNM), a life sciences company providing innovative genetic analysis solutions, today announced the appointment of Charles P. Slacik to its board of directors, effective June 15, 2011. Mr. Slacik has served as chief financial officer and senior vice president of Finance for Beckman Coulter since October 2006. He is […]
Washington, D.C. – Danaher Corporation (NYSE:DHR) announced today that approval from the European Commission had been received for Danaher’s proposed acquisition of Beckman Coulter. This was the last applicable regulatory approval with respect to Danaher’s previously announced tender offer to acquire all of the outstanding shares of Beckman Coulter for $83.50 per share in cash. […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
